NOS2 Antikörper (Sepharose)
Kurzübersicht für NOS2 Antikörper (Sepharose) (ABIN1690551)
Target
Alle NOS2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (AA 14-100) antibody
NOS2 Reaktivität: Human, Maus, Ratte, Huhn WB, ELISA, FACS, IHC (p), IF (p), IF (cc), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 2, Inducible (NOS2) antibodyNOS2 Reaktivität: Human, Maus WB, IHC, ELISA, FACS Wirt: Maus Monoclonal 4E5 unconjugated
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (AA 43-213) antibodyNOS2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (AA 518-694) antibodyNOS2 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (AA 830-860) antibodyNOS2 Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB18210 unconjugated
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (Thr177) antibodyNOS2 Reaktivität: Human, Maus, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (AA 500-730) antibodyNOS2 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (C-Term) antibodyNOS2 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (AA 533-696) antibodyNOS2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 2, Inducible (NOS2) (AA 533-696) antibodyNOS2 Reaktivität: Human WB Wirt: Maus Monoclonal C6 unconjugated
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C
-
-
- NOS2 (Nitric Oxide Synthase 2, Inducible (NOS2))
-
Andere Bezeichnung
- NOS2
-
Pathways
- Retinoic Acid Receptor Signaling Pathway, Cellular Response to Molecule of Bacterial Origin, Inositol Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-
